Cargando...

Transition mutations in the 23S rRNA of erythromycin-resistant isolates of Mycoplasma pneumoniae.

Erythromycin is the drug of choice for treatment of Mycoplasma pneumoniae infections due to its susceptibility to low levels of this antibiotic. After exposure of susceptible strains to erythromycin in vitro and in vivo, mutants resistant to erythromycin and other macrolides were isolated. Their phe...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Lucier, T S, Heitzman, K, Liu, S K, Hu, P C
Formato: Artigo
Idioma:Inglês
Publicado: 1995
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC163027/
https://ncbi.nlm.nih.gov/pubmed/8593017
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!